SG biotech firm Lion TCR bags $40m funding from Chinese investors 

SG biotech firm Lion TCR bags $40m funding from Chinese investors 

A worker pulls a cart under the Liede Bridge over the Pearl River in Guangzhou, China, on Wednesday, Nov. 1, 2017. Photographer: Qilai Shen/Bloomberg

Singapore-headquartered biotech company Lion TCR has raised $40 million in a Series B2 funding round led by state investor Guangzhou Industrial Investment and Capital Operation Holding Group, according to a company statement.

Edited by: Joymitra Rai